BLUME-JENSEN PETER (President and CEO) reported 2 transactions at ACRIVON THERAPEUTICS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 2/18/2026ACC: 0000905148-26-000934
DirectorOfficer· President and CEO
Since Mar 2026
-1.88K
Net shares
Net seller
$3.1K
Total sold
0
Open market trades
0B · 0S
2
Total transactions
1.88K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−1.30K
Price / share
$1.63
Trade value
$2.12K
% of position
0.1%
2/14/2026
2.10M→2.09M
Common Stock
Indirect
Shares
−579.00
Price / share
$1.63
Trade value
$943.77
% of position
0.2%
2/14/2026
314.71K→314.13K
Total
Net shares
−1.88K
Net value
-$3.07K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/14/2026 | F · Tax Withholding | −1.30K | $1.63 | $2.12K | 0.1% | 2.10M | 2.09M |
| Common Stock Indirect | 2/14/2026 | F · Tax Withholding | −579.00 | $1.63 | $943.77 | 0.2% | 314.71K | 314.13K |
| Total | −1.88K | -$3.07K | ||||||
Derivative Transactions0
No derivative transactions reported